News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016
News Daily News Pharmacists Can Take an Active Role in Lowering CV Risk Factors, Likelihood of Events Michael H. Wilson June 21, 2016
News Daily News Experts Agree: Lower Blood Pressure Is Better, but What’s a Realistic Target? Todd Neale June 15, 2016
News Daily News Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel Michael O'Riordan June 09, 2016
News Conference News EAS 2016 Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts Yael L. Maxwell June 06, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues Michael O'Riordan February 15, 2016
News Daily News Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis Michael O'Riordan January 26, 2016
News Daily News For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques Todd Neale December 20, 2015
News Daily News NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication Michael O'Riordan December 08, 2015
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015
News Conference News AHA 2015 AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More Shelley Wood November 05, 2015